Medical devices industry joins forces to sway future French reimbursement system
This article was originally published in Clinica
The medical devices industry has the opportunity to influence the future pricing of medical products sold to the private healthcare sector in France. The French government has given the industry until November 1 to propose both short and long-term changes to the French private healthcare sector evaluation and product pricing system, the TIPS.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.